Teligent Weighs Sales Of Non-Core Assets
Seeking Funds To Unlock Potential Of New Injectables Facility
US topicals, ophthalmics and injectables generics player Teligent has asked an investment bank to help it explore selling off non-core assets. The New Jersey-based firm wants funds to help capitalize on its newly built injectables facility.
